AGENT ANTICANCEREUX

• 收藏
• 分享

专利权人:

LTD.;EISAI R&D MANAGEMENT CO.

发明人:

ODAGAMI, TAKENAO,KOUJI, HIROYUKI,OZAWA, YOICHI,HORI, YUSAKU

申请号：

CA2988707

公开号：

CA2988707A1

申请日:

2016.06.15

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The purpose of the present invention is to provide a cancer treatment drug having excellent therapeutic effect. The present invention combines a CBP/catenin inhibitor and an immune checkpoint inhibitor for treating cancer, and, as a result, not only the therapeutic effect against cancer is increased but treatment can be also effectively performed on patients with cancer less susceptible to the immune checkpoint inhibitor alone.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/